Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04649359 |
|---|---|
| Brief Title: | MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb |
| First Submitted : | November 6, 2020 |
| First Submitted that Met QC Criteria : | November 24, 2020 |
| First Posted : | December 2, 2020 |
| Last Update Submitted that Met QC Criteria : | April 14, 2022 |
| Last Update Posted : | April 18, 2022 |